vs

Side-by-side financial comparison of dLocal Ltd (DLO) and Sotera Health Co (SHC). Click either name above to swap in a different company.

dLocal Ltd is the larger business by last-quarter revenue ($337.9M vs $303.4M, roughly 1.1× Sotera Health Co). dLocal Ltd runs the higher net margin — 16.5% vs 11.5%, a 5.0% gap on every dollar of revenue. On growth, dLocal Ltd posted the faster year-over-year revenue change (65.2% vs 4.6%). dLocal Ltd produced more free cash flow last quarter ($99.8M vs $52.4M).

dLocal Limited is a Uruguayan financial technology company. It provides cross-border payments connecting global merchants to emerging markets.

Sotera Health Co is a global provider of end-to-end medical safety solutions. It offers sterilization services, analytical laboratory testing, and regulatory advisory support for medical device manufacturers, pharmaceutical firms, and food and consumer product companies, helping clients meet industry standards and ensure product safety for end users worldwide.

DLO vs SHC — Head-to-Head

Bigger by revenue
DLO
DLO
1.1× larger
DLO
$337.9M
$303.4M
SHC
Growing faster (revenue YoY)
DLO
DLO
+60.7% gap
DLO
65.2%
4.6%
SHC
Higher net margin
DLO
DLO
5.0% more per $
DLO
16.5%
11.5%
SHC
More free cash flow
DLO
DLO
$47.4M more FCF
DLO
$99.8M
$52.4M
SHC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DLO
DLO
SHC
SHC
Revenue
$337.9M
$303.4M
Net Profit
$55.6M
$34.8M
Gross Margin
34.3%
54.7%
Operating Margin
18.6%
23.2%
Net Margin
16.5%
11.5%
Revenue YoY
65.2%
4.6%
Net Profit YoY
87.3%
182.8%
EPS (diluted)
$0.18
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DLO
DLO
SHC
SHC
Q4 25
$337.9M
$303.4M
Q3 25
$282.5M
$311.3M
Q2 25
$294.3M
Q1 25
$254.5M
Q4 24
$204.5M
$290.2M
Q3 24
$185.8M
$285.5M
Q2 24
$276.6M
Q1 24
$248.2M
Net Profit
DLO
DLO
SHC
SHC
Q4 25
$55.6M
$34.8M
Q3 25
$141.3M
$48.4M
Q2 25
$8.0M
Q1 25
$-13.3M
Q4 24
$29.7M
$12.3M
Q3 24
$90.8M
$17.0M
Q2 24
$8.8M
Q1 24
$6.3M
Gross Margin
DLO
DLO
SHC
SHC
Q4 25
34.3%
54.7%
Q3 25
36.5%
57.0%
Q2 25
56.6%
Q1 25
53.2%
Q4 24
40.9%
56.6%
Q3 24
42.1%
55.4%
Q2 24
55.2%
Q1 24
51.2%
Operating Margin
DLO
DLO
SHC
SHC
Q4 25
18.6%
23.2%
Q3 25
19.7%
23.4%
Q2 25
6.4%
Q1 25
-5.8%
Q4 24
20.7%
30.0%
Q3 24
22.1%
28.2%
Q2 24
27.8%
Q1 24
21.4%
Net Margin
DLO
DLO
SHC
SHC
Q4 25
16.5%
11.5%
Q3 25
50.0%
15.5%
Q2 25
2.7%
Q1 25
-5.2%
Q4 24
14.5%
4.2%
Q3 24
48.9%
6.0%
Q2 24
3.2%
Q1 24
2.5%
EPS (diluted)
DLO
DLO
SHC
SHC
Q4 25
$0.18
$0.12
Q3 25
$0.17
$0.17
Q2 25
$0.03
Q1 25
$-0.05
Q4 24
$0.09
$0.05
Q3 24
$0.09
$0.06
Q2 24
$0.03
Q1 24
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DLO
DLO
SHC
SHC
Cash + ST InvestmentsLiquidity on hand
$719.9M
$344.6M
Total DebtLower is stronger
$86.7M
$2.1B
Stockholders' EquityBook value
$569.4M
$606.0M
Total Assets
$1.5B
$3.3B
Debt / EquityLower = less leverage
0.15×
3.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DLO
DLO
SHC
SHC
Q4 25
$719.9M
$344.6M
Q3 25
$604.5M
$299.2M
Q2 25
$332.4M
Q1 25
$304.4M
Q4 24
$425.2M
$277.2M
Q3 24
$560.5M
$306.7M
Q2 24
$246.1M
Q1 24
$261.1M
Total Debt
DLO
DLO
SHC
SHC
Q4 25
$86.7M
$2.1B
Q3 25
$63.1M
$2.1B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$39.8M
$2.2B
Q3 24
$2.2B
Q2 24
$2.2B
Q1 24
$2.2B
Stockholders' Equity
DLO
DLO
SHC
SHC
Q4 25
$569.4M
$606.0M
Q3 25
$504.7M
$550.5M
Q2 25
$511.3M
Q1 25
$414.1M
Q4 24
$489.0M
$404.9M
Q3 24
$457.0M
$470.2M
Q2 24
$422.8M
Q1 24
$429.4M
Total Assets
DLO
DLO
SHC
SHC
Q4 25
$1.5B
$3.3B
Q3 25
$1.4B
$3.2B
Q2 25
$3.2B
Q1 25
$3.1B
Q4 24
$1.2B
$3.1B
Q3 24
$3.1B
Q2 24
$3.1B
Q1 24
$3.1B
Debt / Equity
DLO
DLO
SHC
SHC
Q4 25
0.15×
3.53×
Q3 25
0.12×
3.89×
Q2 25
4.34×
Q1 25
5.36×
Q4 24
0.08×
5.49×
Q3 24
4.73×
Q2 24
5.26×
Q1 24
5.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DLO
DLO
SHC
SHC
Operating Cash FlowLast quarter
$100.4M
$103.1M
Free Cash FlowOCF − Capex
$99.8M
$52.4M
FCF MarginFCF / Revenue
29.5%
17.3%
Capex IntensityCapex / Revenue
0.2%
16.7%
Cash ConversionOCF / Net Profit
1.80×
2.96×
TTM Free Cash FlowTrailing 4 quarters
$378.7M
$149.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DLO
DLO
SHC
SHC
Q4 25
$100.4M
$103.1M
Q3 25
$315.0M
$71.2M
Q2 25
$57.4M
Q1 25
$55.5M
Q4 24
$-141.1M
$55.7M
Q3 24
$108.3M
$97.5M
Q2 24
$61.3M
Q1 24
$9.7M
Free Cash Flow
DLO
DLO
SHC
SHC
Q4 25
$99.8M
$52.4M
Q3 25
$313.4M
$35.0M
Q2 25
$26.2M
Q1 25
$35.6M
Q4 24
$-141.6M
$-10.2M
Q3 24
$107.1M
$61.1M
Q2 24
$19.4M
Q1 24
$-25.2M
FCF Margin
DLO
DLO
SHC
SHC
Q4 25
29.5%
17.3%
Q3 25
110.9%
11.2%
Q2 25
8.9%
Q1 25
14.0%
Q4 24
-69.2%
-3.5%
Q3 24
57.6%
21.4%
Q2 24
7.0%
Q1 24
-10.2%
Capex Intensity
DLO
DLO
SHC
SHC
Q4 25
0.2%
16.7%
Q3 25
0.6%
11.6%
Q2 25
10.6%
Q1 25
7.8%
Q4 24
0.2%
22.7%
Q3 24
0.7%
12.7%
Q2 24
15.2%
Q1 24
14.1%
Cash Conversion
DLO
DLO
SHC
SHC
Q4 25
1.80×
2.96×
Q3 25
2.23×
1.47×
Q2 25
7.21×
Q1 25
Q4 24
-4.75×
4.52×
Q3 24
1.19×
5.73×
Q2 24
7.00×
Q1 24
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DLO
DLO

Segment breakdown not available.

SHC
SHC

Transferred At Point In Time$198.4M65%
Nelson Labs$55.2M18%
Nordion$49.8M16%

Related Comparisons